Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 2, 2009, Pages 205-210

  Abo Salem, Osama M ^a   El Edel, Rawhia H ^b   Harisa, Gamal Eldin I ^a   El Halawany, Nermin ^c   Ghonaim, Mabrouk M ^b  

^a AL AZHAR UNIVERSITY   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antioxidants; Diabetes; Nephropathy; Oxidative stress; Propolis

Indexed keywords

ALBUMIN; CATALASE; CREATININE; GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PROPOLIS; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UREA; ANTIOXIDANT; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG DOSE COMPARISON; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL; ALBUMINURIA; ANIMAL; BLOOD; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; ORGAN SIZE; PATHOLOGY; WISTAR RAT;

ALBUMINURIA; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; LIPID PEROXIDATION; MALE; ORGAN SIZE; OXIDATIVE STRESS; PROPOLIS; RATS; RATS, WISTAR;

EID: 65449166419     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Abd El-Hady FK, Hegazi AG and Wollenweber E (2007). Effect of Egyptian propolis on the susceptibility of LDL to oxidative modification and its antiviral activity with special emphasis on chemical composition. Z. Naturforsch., 62(9-10): 645-655
2. Abdel Wahab YH, O'Harte FP, Ratcliff H, McClenaghan NH, Barnett CR and Flatt PR (1996). Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes, 45: 1489-1496. (Pubitemid 26357539)
3. Aebi H (1984). Catalase in vitro. In: Methods in Enzymology, Academic Press, New York, pp.479-500.
4. Altug ME, Serarslan Y, Bal R, Konta AYT, Ekici F, Melek I, Aslan H and Duman T (2008). Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: A biochemical and planimetric study. Brain Res., 1201: 135-142.
5. Auslander W, Haire-Joshu D, Houston C, Rhee CW and Williams JH (2002). A controlled evaluation of staging dietary patterns to reduce the risk of diabetes in African- American women. Diabetes Care, 25: 809-814. (Pubitemid 41094275)
6. Bankova VS, Castro SD and Marcucci MC (2000). Propolis: recent advances in chemistry and plant origin. Apidologie, 31: 3-15.
7. Benguedouar L, Boussenane HN, Wided K, Alyane M, Rouibah H, Lahouel M (2008). Efficiency of propolis extract against mitochondrial stress induced by antineoplasic agents (doxorubicin and vinblastin) in rats. Indian J. Exp. Biol., 46(2):112-119.
8. Benkovi Ac V, Orsolic N, Knezevic AH, Ramic S, Dikic D, Basic I and Kopjar N (2008). Evaluation of the radioprotective effects of propolis and flavonoids in gamma-irradiated mice: the alkaline comet assay study. Biol. Pharm. Bull., 31(1): 167-172.
9. Beutler E, Duron O and Kelly MB (1963). Improved method for the determination of blood glutathione. J. Lab .Clin. Med., 61: 882-888.
10. Burdock GA (1998). Review of the biological properties and toxicity of bee propolis (Propolis). Food Chem. Toxicol. 36: 347-363. (Pubitemid 28255348)
11. Busby DE and Atkins RC (2005). The detection and measurement of microalbuminuria: a challenge for clinical chemistry. Med. Lab.Obs., 37(2): 8-14.
12. Cross JL, deAzevedo MJ, Silveiro SP and Canani H (2005). Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care, 28(1):164-177.
13. Deniz S, Arzu S, Figen I and Gulden C (1997). Lipid peroxidation and antioxidant status in experimental animals. Effects of aging and hypercholesterolemic diet. Clin. Chem. Acta, 265: 77-82.
14. El-Khatib AS, Agha AM, Mahran LGand Khayyal MT (2002). Prophylactic effect of aqueous propolis extract against acute experimental hepatotoxicity in vivo. Z. Naturforsch., 57(3-4): 379-385.
15. Fuliang HU, Hepburn HR, Xuan H, Chen M, Daya S and Radloff SE (2005). Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol. Res., 51(2): 147-152. (Pubitemid 40040545)
16. Gispen WH and Biessels GJ (2000). Cognition and synaptic dietary patterns to reduce the risk of diabetes in African-plasticity in diabetes mellitus. Trends Neurosci., 23: 542-549.
17. Ichikawa H, Satoh K, Tobe T, Yasuda I, Ushio F, Matsumoto K, Endo K and Ookubo C (2002). Free radical scavenging activity of propolis. Redox Rep., 7(5): 347-350. (Pubitemid 36032931)
18. Inokuchi Y, Shimazawa M, Nakajima Y, Suemori S, Mishima S and Hara H (2006). Brazilian green propolis protects against retinal damage in vitro and in vivo. Evid. Based Complement. Alternat. Med., 3(1): 71-77. (Pubitemid 43999654)
19. Jasprica I, Mornar A, Debeljak Z, Smolcic-Bubalo A, Medic-Saric M, Mayer L, Romic Z, Bucan K, Balog T, Sobocanec S and Sverko V (2007). In vivo study of propolis supplementation effects on antioxidative status and red blood cells. J. Ethnopharmacol., 110(3): 548-654. (Pubitemid 46386367)
20. Jee SH, Kim HJ and Lee J (2005). Obesity insulin resistance and cancer risk. Yonsei. Med. J., 46: 449-455. (Pubitemid 41283053)
21. Luan J, Wang N and Tian L (2000). Study on the pharmacologic effect of propolis. Zhong Yao Cai., 23(6): 346-348.
22. Marjani A (2005). Plasma lipid peroxidation zinc and erythrocyte Cu-Zn superoxide dismutase enzyme activity in patients with type 2 diabetes mellitus in Gorgan City (South East of the Caspian Sea). Internet J. Endocrinol., 2(1): 1647-1648.
23. Masumi Y, Hitoshi K, Kouhei K and Mikio I (2005). Effect of combined vitamin E and insulin administration on renal damage in diabetic rats fed a high cholesterol diet. Biol. Pharm. Bull., 28(11): 2080-2086. (Pubitemid 41634255)
24. Montilla P, Barcos M, Munoz M, Castaneda I and Tunez I (2005). Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J. Biochem. Mol. Biol., 38(5): 539-544. (Pubitemid 43240987)
25. Nakai S, Shinzato T, Nagura Y, Masakane I, Kitaoka T, Shinoda T, Yamazaki C, Sakai R, Morita O and Iseki K (2005). An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther. Apher. Dial., 9: 431-458. (Pubitemid 43923972)
26. Nobecourt E, Jacqueminet S, Hanset B, Chantepie S, Grimaldi A, Chapman MJ and Kontush A (2005). Defective antioxidative activity of small dense HDL 3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycemia. Diabetologia, 48(3): 529-538. (Pubitemid 40487300)
27. Oktem F, Ozguner F, Sulak O, Olgar S, Akturk O, Yilmaz H and Altuntas I (2005). Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Mol. Cell. Biochem., 277(1-2): 109-115. (Pubitemid 41236192)
28. Okutan H, Ozcelik N, Yilmaz HR and Uz E (2005). Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin. Biochem., 38(2): 191-196. (Pubitemid 40092465)
29. Ozguner F, Oktem F, Armagan A, Yilmaz R, Koyu A, Demirel R, Vural H and Uz E (2005). Comparative analysis of the protective effects of melatonin and caffeic acid phenethyl ester (CAPE) on mobile phoneinduced renal impairment in rat. Mol. Cell Biochem., 276(1-2): 31-37. (Pubitemid 41236206)
30. Shinohara R, Ohta Y, Hayashi T and Ikeno T (2002). Evaluation of antilipid peroxidative action of propolis ethanol extract. Phytother Res., 16(4): 340-347. (Pubitemid 34700272)
31. Sobocanec S, Sverko V, Balog T, Saric AA, Rusak G, Likic AS, Kusic AB, Katalinic AV, Radic AS and Marotti T (2006). Oxidant/antioxidant properties of Croatian native propolis. J. Agric. Food Chem., 54(21): 8018-8026. (Pubitemid 44785379)
32. Sun F, Hayami S, Haruna S, Ogiri Y, Tanaka K, Yamada Y, Ikeda K, Yamada H, Sugimoto H, Kawai N and Kojo S (2000). In vivo antioxidative activity of propolis evaluated by the interaction with vitamins C and E and the level of lipid hydroperoxides in rats. J. Agric Food Chem., 48(5): 1462-1465. (Pubitemid 30331473)
33. Sun Y, Oberley LW and Li YA (1998). Simple method for clinical assay of superoxide dismutase. Clin. Chem. 34: 479-500.
34. Tan-No K, Nakajima T, Shoji T, Nakagawasai O, Niijima F , Ishikawa M, Endo Y, Sato T, Satoh S and Tadano T (2006). Anti-inflammatory effect of propolis through inhibition of nitric oxide production on carrageenininduced mouse paw edema. Biol. Pharm. Bull., 29(1): 96-99. (Pubitemid 43036702)
35. Tazawa S, Warashina T and Noro T (1999). Studies on the constituents of Brazilian propolis II. Chem. Pharm. Bull., 47: 1388-1392.
36. Valadares BL, Graf U and Span AMA (2008). Inhibitory effects of water extract of propolis on doxorubicininduced somatic mutation and recombination in Drosophila melanogaster Food Chem. Toxicol., 46(3): 1103-1110.
37. Yamabe N, Yokozawa T, Oya T and Kim M (2006). Therapeutic potential of (-)-epigallocatechin 3-Ogallate on renal damage in diabetic nephropathy model rats. J. Pharmacol. Exp. Ther., 319(1): 228-236. (Pubitemid 44455127)
38. Yin X, Zhang Y, Wu H, Zhu X, Zheng X, Jiang S, Zhuo H, Shen J, Li and Qiu J (2004). Protective effects of Astragalus Saponin I on early stage of diabetic nephropathy in rats. J. Pharmacol. Sci., 95: 256-266. (Pubitemid 38899696)